Novartis Korea executives charged with bribing doctors
In response, Swiss pharmaceutical company expressed regret through a statement, but also said without elaborating that such conduct would not have been sanctioned by the "most senior management" at Novartis Korea.
According to the prosecution, Novartis' South Korean associates, including former Novartis Korea chief executive Moon Hak-sun, tried to go around the laws by funding academic events organized by publishers of medical journals, where the invited doctors received kickbacks disguised as attendance fees.